Your browser doesn't support javascript.
SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience.
Meti, Nicholas; Tahmasebi, Houman; Leahey, Angela; Boudreau, Angela; Thawer, Alia; Stewart, Janice; Reason, Paige; Albright, Kirsty; Leis, Jerome A; Katz, Kevin; Cheung, Matthew C; Singh, Simron.
  • Meti N; Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Tahmasebi H; Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Leahey A; Division of Medical Oncology and Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
  • Boudreau A; Division of Medical Oncology and Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
  • Thawer A; Department of Pharmacy, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
  • Stewart J; Division of Medical Oncology and Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
  • Reason P; Division of Medical Oncology and Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
  • Albright K; Division of Medical Oncology and Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
  • Leis JA; Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Katz K; Division of Infectious Diseases, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON M4N 3M5, Canada.
  • Cheung MC; Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Singh S; Department of Laboratory Medicine, North York General Hospital, Toronto, ON M2K 1E1, Canada.
Curr Oncol ; 28(1): 278-282, 2021 01 06.
Article in English | MEDLINE | ID: covidwho-1011431
Semantic information from SemMedBD (by NLM)
1. Malignant Neoplasms PROCESS_OF Patients
Subject
Malignant Neoplasms
Predicate
PROCESS_OF
Object
Patients
2. Malignant Neoplasms PROCESS_OF Patients
Subject
Malignant Neoplasms
Predicate
PROCESS_OF
Object
Patients
ABSTRACT
Patients with cancer are more vulnerable to severe COVID-19. As a result, routine SARS-CoV-2 testing of asymptomatic patients with cancer is recommended prior to treatment. However, there is limited evidence of its clinical usefulness. The objective of this study is to evaluate the value of routine testing of asymptomatic patients with cancer. Asymptomatic patients with cancer attending Odette Cancer Centre (Toronto, ON, Canada) were tested for SARS-CoV-2 prior to and during treatment cycles. Results were compared to positivity rates of SARS-CoV-2 locally and provincially. All 890 asymptomatic patients tested negative. Positivity rates in the province were 1.5%, in hospital were 1.0%, and among OCC's symptomatic cancer patients were 0% over the study period. Given our findings and the low SARS-CoV-2 community positivity rates, we recommend a dynamic testing model of asymptomatic patients that triggers testing during increasing community positivity rates of SARS-CoV-2.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asymptomatic Infections / COVID-19 Testing / SARS-CoV-2 / COVID-19 / Neoplasms Type of study: Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: Curr Oncol Year: 2021 Document Type: Article Affiliation country: Curroncol28010032

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Asymptomatic Infections / COVID-19 Testing / SARS-CoV-2 / COVID-19 / Neoplasms Type of study: Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: North America Language: English Journal: Curr Oncol Year: 2021 Document Type: Article Affiliation country: Curroncol28010032